Why imaging is key to managing geographic atrophy
Paying attention to high-resolution OCT is more important than ever
NIDEK announces CE mark for IOL injector, launch of new OCT device
The NP-1/NP-1C preloaded IOL injector has already been made available in parts of Asia
Metabolomics and the molecular approach to glaucoma diagnosis
Metabolomics reflects the physiological state of a tissue and provides information about interactions between genetics, environment and lifestyle
New therapeutic targets, drug development for retinitis pigmentosa
Simply slowing disease progression is no longer enough
Recap: The Association for Research in Vision and Ophthalmology takes Seattle
ARVO attendees took a deep dive into trends and explored the near future of vision science
Factors affecting ROP development in first 8 weeks after birth
Study could influence screening protocols for neonatal patients
Risk factors for retinal detachment in Marfan syndrome after paediatric lens removal
Investigators put forth a list of considerations for surgeons ahead of lens removalin paediatric patients
A safe and effective non-ablative treatment with multiple applications for the ocular surface
Plasma emission can act as a therapeutic for blepharitis, dry eye and other ocular disease
Topical drop treatment for full-thickness macular hole closure
Investigators reported findings from the first study of successful macular hole closure using topical therapy
Safety and efficacy findings from the XEN45 glaucoma implant
Investigators assessed the XEN45 implant alone and in combination with phacoemulsification
SLT delivery by non-medical ophthalmic practitioners serves patients with glaucoma
Early results indicate that trained optometrists delivered safe and effective laser treatments
Espansione Group receives CE Mark approval for eye-light® photobiomodulation device
The flagship, light-based technology has received approval for applications in the anterior and posterior segments
Global leaders in cataract run the Olympic gauntlet of surgery
Surgeons shared practical pearls in a “Cataract Olympiad"
The 16th European Glaucoma Society Congress convenes in Dublin
This year’s meeting will take place in Ireland’s technology and business hub
Monitoring glaucoma progression rate to preserve patients’ vision
Three approaches to examination give a comprehensive overview
European Commission grants Marketing Authorisation for bevacizumab gamma
The approval also grants Outlook Therapeutics an initial 10 years of market exclusivity in the EU for bevacizumab gamma (LYTENAVA)
Dopavision announces topline results for MyopiaX trial for slowing paedatric myopia progression
The light-based therapy functions using a virtual reality headset
Racing against microbial keratitis
Challenging choices force ophthalmologists to weigh long-term outcomes
Role of ferroptosis in bacterial keratitis
Inhibiting ferroptosis could be crucial to reducing inflammation
Post hoc analysis shows how pegcetacoplan may impact RPE atrophy
Analysis of the OAKS and DERBY trials showed reduced growth rates of SD-OCT biomarkers for geographic atrophy
Professor Noemi Lois awarded Edinburgh King James IV Professorship by The Royal College of Surgeons
Professor Lois accepted the award at the Royal College of Ophthalmologists Annual Congress
United States FDA approves two aflibercept 2 mg biosimilars
The agency issued approval for Yesafili, from Biocon Biologics, and Opuviz, from Samsung Bioepis and Biogen
Predicting visual acuity with a machine learning system
For decoding biomarkers, a multistage system is just the beginning
The evolving role of vitreosurgical simulators in surgical training
Need for accuracy results in optimisation of training for novice surgeons
For younger patients with mid-range myopia, consider phakic IOLs
The implantable lenses can offer an advantage over laser surgery
The good, the bad and the maybe in ocular gene therapies
Promising innovations are not one-size-fits-all
Outlook Therapeutics submits UK Marketing Authorisation Application for wet AMD treatment
The submission for bevacizumab gamma (ONS-5010/LYTENAVA) follows a positive opinion from the CHMP in March
ARVO 2024: Trial design and increased accuracy of meibomian gland morphology measurements
At the 2024 ARVO meeting, Andrew D. Pucker, OD, PhD, presented a paper on measuring meibomian gland morphology
ARVO 2024: Mutation agnostic optogenetic programme demonstrates possible treatment for patients with severe retinal degeneration
Allen Ho, MD, presented on the 12-month results of an mutation agnostic optogenetic programme at the ARVO 2024 meeting
Going beyond the clinical setting in ophthalmic mentorship
Three leaders in glaucoma research, retina care and refractive surgery share their expertise
